You are here: Industry Insights > EU

News List

New order: European cancer coalition calls for cancer treatment overhaul pharmatimes
February 03, 2022
Coalition urges reformation of EU-wide drug research and development to drive treatment optimisation.
EU drug regulator OKs Pfizer COVID pill for high-risk patients ExpressPharma
January 29, 2022
The endorsement by EMA for a conditional approval, if followed as usual by the European Commission, allows EU member states to deploy the drug after the regulator gave guidance for its emergency use late last year.
EU Eases COVID-19 Travel Rules Within the Bloc for Fully Vaccinated drugs.com
January 26, 2022
European Union residents should be able to move freely between the 27 member nations if they have been vaccinated in the past
Fidelity Health Services sets to venture into the US and EU markets expresspharma
August 13, 2021
Fidelity Health Services is geared up to expand its territorial footprint in the US and EU regions. This expansion will allow the company to fulfil the mushrooming needs of pharmaceutical companies based in these markets, the company said in a statement.
European Union Passes U.S. in COVID-19 Vaccination Rates drugs
August 10, 2021
After lagging behind for months, the European Union (EU) now has a higher COVID-19 vaccination rate than the United States.
Forxiga Approved in EU to Treat Chronic Kidney Disease americanpharmaceuticalreview
August 10, 2021
AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the European Union (EU) for the treatment of chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D).
EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds pharmatimes
July 28, 2021
Moderna’s COVID-19 vaccine has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for use in adolescents aged 12 to 17 years of age.
EU begins real-time review of Sanofi-GSK COVID-19 vaccine expresspharma
July 22, 2021
The decision to start the "rolling review" of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and early-stage clinical trials in adults, the European Medicines Agency (EMA) said.
EU approval for self-administered Crysvita pharmatimes
July 21, 2021
Kyowa Kirin has received approval in the EU for the self-administration option of its X-linked hypophosphataemia (XLH) treatment Crysvita.
EU gets partial win in AstraZeneca Covid-19 vaccine supply case pharmaceutical-technology
June 23, 2021
The Court of First Instance in Brussels, Belgium, has ordered AstraZeneca to supply 80.2 million doses of its Covid-19 vaccine by 27 September, representing only a partial win for the EU.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page